SHR-1701 Combined with SHR2554 and BP102 for MCRC

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Response to oncologic treatment in mCRC is currently limited.

PHASE2

Fudan University

SHR-1701